Earnings decline in the prescription pharmaceutical wholesale business due to drug price revisions
Revenue increased in the wholesale business for prescription pharmaceuticals and related products, driven by market growth and the end of the bid designation suspension period, while profit declined due to the impact of drug price revisions.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.